WHO ICTRP trial
Role of curcumin curcumin (NCB02) enemas in treating ulcerative colitis.
CTRI/2011/04/001695 · Clinical Trials Registry India (CTRI) · Not Recruiting
Key facts
| Trial ID | CTRI/2011/04/001695 |
|---|---|
| Public title | Role of curcumin curcumin (NCB02) enemas in treating ulcerative colitis. |
| Scientific title | Evaluation of efficacy and tolerability of curcumin enemas in ulcerative colitis - - |
| Primary sponsor | Dr Vinnet Ahuja |
| Registry | Clinical Trials Registry India (CTRI) |
| Recruitment status | Not Recruiting |
| Study type | Interventional |
| Phase | Phase 2/ Phase 3 |
| Countries | India;India |
| Conditions | Health Condition 1: null- Active distal ulcerative colitis |
| Interventions | Intervention1: Curcumin (NCB02): Each curcumin enema contained 140 mg of curcumin dissolved in 20 ml of water. Patients were advised to take the enema preparation in the night prior to sleep. All the patients, in addition to trail drug… |
| Registration date | Apr 25, 2011 |
| Target size | 96 |
| Secondary IDs | NIL |
| Registry page | ctri.nic.in |
At a glance
- No Results available
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About WHO ICTRP trial registrations
The WHO ICTRP combines trial registrations from primary registries worldwide into a single searchable index. Contact and ethics-committee details are not shown here.
Source: World Health Organization (WHO), International Clinical Trials Registry Platform (ICTRP) · Source date: